Biotechnology
GNFT
3.63
price up icon0.00%   0.00
after-market アフターアワーズ： 3.63

Genfit Adr (GNFT)
full-star
loading
概要 ニュース 株価時系列 ディスカッション 予測
前日終値:
$3.63
開ける：
$3.61
24時間の取引高:
6,007
Relative Volume:
1.50
時価総額：
$181.51M
収益：
-
当期純損益:
-
株価収益率:
-4.9448
EPS:
-0.7341
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-14.08%
1か月 パフォーマンス:
-17.15%
6か月 パフォーマンス:
+2.83%
1年 パフォーマンス:
-31.25%
1日の値動き範囲:
Value
$3.61
$3.75
1週間の範囲:
Value
$3.60
$4.3825
52週間の値動き範囲:
Value
$2.55
$6.4229

Genfit Adr Stock (GNFT) Company Profile

Name
名前
Genfit Adr
Name
セクター
Healthcare (1150)
Name
産業
Biotechnology (643)
Name
電話
-
Name
住所
-
Name
職員
180
Name
Twitter
@genfit_pharma
Name
次回の収益日
2025-09-22
Name
最新のSEC提出書
Name
GNFT's Discussions on Twitter

GNFT を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
GNFT
Genfit Adr
 3.63 181.51M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
 376.62 97.36B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
 576.98 60.19B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
 458.37 59.56B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
 729.76 44.94B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
 329.84 36.14B 3.81B -644.79M -669.77M -6.24

Genfit Adr Stock (GNFT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-08-19 再開されました H.C. Wainwright Buy
2021-12-20 アップグレード H.C. Wainwright Neutral → Buy
2020-07-23 アップグレード Stifel Hold → Buy
2020-06-25 開始されました BofA/Merrill Underperform
2020-05-13 ダウングレード Kepler Buy → Reduce
2020-05-12 ダウングレード Barclays Overweight → Equal Weight
2020-05-12 ダウングレード H.C. Wainwright Buy → Neutral
2019-10-29 繰り返されました B. Riley FBR Buy
2019-06-25 開始されました Stifel Hold
2019-04-24 開始されました SVB Leerink Outperform
2019-04-22 開始されました Barclays Overweight
すべてを表示

Genfit Adr (GNFT) 最新ニュース

pulisher
Sep 24, 2025

HC Wainwright Has Lowered Expectations for GENFIT (NASDAQ:GNFT) Stock Price - MarketBeat

Sep 24, 2025
pulisher
Sep 11, 2025

European ADRs Dip Slightly As Biotech Stocks Jump And Drop - Finimize

Sep 11, 2025
pulisher
Aug 20, 2025

GENFIT (NASDAQ:GNFT) Coverage Initiated by Analysts at HC Wainwright - Defense World

Aug 20, 2025
pulisher
Aug 15, 2025

European Biopharma ADRs: A Strategic Play in a Volatile Market - AInvest

Aug 15, 2025
pulisher
Jul 10, 2025

GENFIT (NASDAQ:GNFT) Shares Up 0.7% – Time to Buy? - Defense World

Jul 10, 2025
pulisher
Jun 30, 2025

European ADRs: Navigating Sectoral Divergence in a Volatile Market - AInvest

Jun 30, 2025
pulisher
Jun 27, 2025

European Biopharma Leads Gains In ADR Market Surge - Finimize

Jun 27, 2025
pulisher
Jun 27, 2025

European Biotech ADRs Lead the Charge: A Sector on the Verge of Breakthrough Growth - AInvest

Jun 27, 2025
pulisher
May 31, 2025

European ADRs Show Strength With Genfit And Novo Nordisk Leading Gains - Finimize

May 31, 2025
pulisher
May 22, 2025

European ADRs Show Optimism As Genfit Leads Gains - Finimize

May 22, 2025
pulisher
May 07, 2025

European ADRs See Mixed Results With Modest Gains - Finimize

May 07, 2025
pulisher
Apr 11, 2025

European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading - TradingView

Apr 11, 2025
pulisher
Apr 09, 2025

European ADRs Climb As Biopharmaceuticals Lead The Charge - Finimize

Apr 09, 2025
pulisher
Apr 08, 2025

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading - TradingView

Apr 08, 2025
pulisher
Apr 03, 2025

European Equities Traded in the US as American Depositary Receipts Fall in Thursday Trading - TradingView

Apr 03, 2025
pulisher
Apr 01, 2025

European Equities Traded in the US as American Depositary Receipts Tread Water in Tuesday Trading - TradingView

Apr 01, 2025
pulisher
Mar 28, 2025

European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading - TradingView

Mar 28, 2025
pulisher
Mar 27, 2025

European Equities Traded in the US as American Depositary Receipts Edge Higher in Thursday Trading - TradingView

Mar 27, 2025
pulisher
Mar 26, 2025

European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading - TradingView

Mar 26, 2025
pulisher
Mar 24, 2025

European Equities Traded in the US as American Depositary Receipts Higher in Monday Trading - TradingView

Mar 24, 2025
pulisher
Mar 18, 2025

European Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading - TradingView

Mar 18, 2025
pulisher
Mar 14, 2025

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Down for Week - TradingView

Mar 14, 2025
pulisher
Mar 03, 2025

European Equities Traded in the US as American Depositary Receipts Surge Higher in Monday Trading - TradingView

Mar 03, 2025
pulisher
Feb 28, 2025

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Remain Flat for Week - TradingView

Feb 28, 2025
pulisher
Jun 10, 2024

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis - GlobeNewswire

Jun 10, 2024
pulisher
Dec 07, 2023

Ipsen confirms U.S. FDA grants priority review for New Drug - GlobeNewswire

Dec 07, 2023
pulisher
Nov 13, 2023

Results from Ipsen’s ELATIVE® pivotal Phase III trial of - GlobeNewswire

Nov 13, 2023
pulisher
Dec 17, 2021

Ipsen and GENFIT Enter Into Exclusive Licensing Agreement for Elafibranor, a Phase III Asset Evaluated in Primary Biliary Cholangitis, as Part of a Long-Term Global Partnership - Business Wire

Dec 17, 2021

Genfit Adr (GNFT) 財務データ

Genfit Adr (GNFT) の財務データはありません。詳細については、他の銘柄を確認してください。

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

GNFTに似た銘柄

biotechnology RPRX
$35.77
price down icon 1.30%
biotechnology INCY
$84.16
price down icon 0.45%
biotechnology GMAB
$29.45
price up icon 2.51%
biotechnology BNTX
$99.75
price up icon 1.51%
biotechnology INSM
$141.00
price down icon 3.01%
biotechnology ONC
$329.84
price up icon 0.23%
Yahooで開く | Google で開く | Finviz で開く | マーケットウォッチで開く | エドガーでオープン | ロイターで開く
大文字化:     |  ボリューム (24 時間):